CDCl3) δ 7.45 (dd, J = 4.0 Hz, 8.0 Hz, 2H), 7.14–7.10 (comp,
2H), 7.02–6.94 (comp, 4H), 6.65 (d, J = 8.0 Hz, 1H), 5.53
(t, J = 8.0 Hz, 1H), 5.22 (dd, J = 8.0 Hz, 12.0 Hz, 1H), 4.91(dd,
J = 4.0 Hz, 12.0 Hz, 1H), 4.76 (dd, J = 4.0 Hz, 8.0 Hz, 1H),
4.04 (ddd, J = 4.0 Hz, 8.0 Hz, 12.0 Hz, 1H), 3.86 (s, 3 H), 3.83
(dd, J = 4.0 Hz, 12.0 Hz, 1H) 3.66 (dd, J = 8.0 Hz, 12.0 Hz,
1H); 2.41 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 200.0, 188.9,
162.4 (d, JCF = 200 Hz), 162.4 (d, JCF = 190 Hz), 161.3, 144.0,
140.8, 134.4 (d, JCF = 0.3 Hz), 131.8 (d, JCF = 0.3 Hz), 130.2
(d, JCF = 10 Hz), 129.8 (d, JCF = 10 Hz), 116.4 (d, JCF = 20
Hz), 116.0 (d, JCF = 20 Hz), 77.5, 77.2, 52.7, 48.9, 45.5, 42.9,
8.0 Hz, 1H), 5.60 (t, J = 8.0 Hz, 1H), 5.23 (dd, J = 8.0 Hz, 12.0
Hz, 1H), 5.07 (dd, J = 4.0 Hz, 12.0 Hz, 1H), 5.06 (comp, 1H),
4.65 (dd, J = 8.0 Hz, 12.0 Hz, 1H), 4.56 (dd, J = 4.0 Hz, 12.0
Hz, 1H), 4.27 (ddd, J = 4.0 Hz, 8.0 Hz, 12.0 Hz, 1H), 3.56
(s, 3H), 2.39 (s, 3H); 13C NMR (100 MHz, CDCl3) 198.7,
188.4, 160.6, 143.0, 142.3, 141.6, 139.9, 137.4, 137.1, 128.7,
127.5, 126.3, 126.0 (d, JCF = 3 Hz), 125.6 (d, JCF = 3 Hz),
123.7 (q, JCF = 270 Hz), 77.1, 77.1, 52.5, 49.0, 46.4, 42.07,
1
27.1; visible signals of the minor isomer: H NMR (400 MHz,
CDCl3) δ 7.13 (d, J = 8.0 Hz, 2H), 7.11 (d, J = 8.0 Hz, 2H),
5.76 (t, J = 8.0 Hz, 1H), 4.12 (s, 3H), 2.19 (s, 3H); 13C NMR
(100 MHz, CDCl3) 129.9, 127.3, 125.2 (d, JCF = 3 Hz), 125.1(d,
1
27.5; visible signals of the minor isomer: H NMR (400 MHz,
CDCl3) δ 7.24 (dd, J = 4.0 Hz, 8.0 Hz, 2H), 7.12–7.10 (comp,
4H), 7.07 (dd, J = 4.0 Hz, 8.0 Hz, 2H), 6.84 (d, J = 8.0 Hz, 1H),
5.52 (comp, 1H), 4.99 (dd, J = 4.0 Hz, 12.0 Hz, 1H), 4.56 (dd,
J = 8.0 Hz, 12.0 Hz, 1H), 4.48 (dd, J = 4.0 Hz, 8.0 Hz, 1H),
4.15–4.09 (comp, 1H), 3.86–3.81 (1H), 3.63–3.68 (1H), 2.37
(s, 1H); 13C NMR (100 MHz, CDCl3) δ 199.1, 188.9, 161.5,
JCF = 3 Hz), 53.1, 48.7, 44.1, 40.8; IR (neat): 2960, 2923, 2853,
2154, 1714, 1679, 1651, 1621, 1554, 1439 cm−1; HRMS (ESI)
for C27H22F6N4O8 [M + H]+ calcd 645.1419; found 645.1425.
Synthesis of methyl 2,6-dihydroxy-3-methyl-5-[1-(1-furyl)-2-
nitroethyl]benzoate (12e). To a 4 dram vial was added zinc
triflate (2 mg, 0.005 mmol), followed by enone 2 (50 mg,
0.45 mmol) and 2 mL of dry DCM. With stirring at room temp-
erature enol diazoacetate 1 (180 mg, 0.70 mmol) was added all
at once, and the yellow solution was allowed to react overnight.
After 16 h, 2.0 equiv. of 2-(2-nitrovinyl)furan (150 mg,
1.00 mmol) was added, followed by 5 mol% triethylamine
(3 mg, 0.03 mmol) when 2-(2-nitrovinyl)furan was fully dis-
solved. The color of the solution turned from yellow to deep red
upon addition of the base. The reaction solution was stirred at
room temperature for 24 h during which time the color of the
solution became darker. The resulting solution was concentrated
under reduced pressure, and the crude residue was purified by
silica gel chromatography, eluting with 1 : 6 EtOAc–hexane,
to give 90 mg (0.28 mmol, 63%) of a yellow solid as major
product 12e. In addition, 58 mg (0.12 mmol, 26%) double
addition by-product was obtained as a mixture of multiple
isomers which could not be separated by chromatography. 12e:
1H NMR (400 MHz, CDCl3) δ 9.94 (br, 2H), 7.37 (s, 1H), 7.02
(s, 1H), 6.32 (d, J = 4.0 Hz), 6.18 (J = 4.0 Hz), 5.25 (t, J = 8.0
Hz), 4.91 (hept, J = 8.0 Hz), 4.07 (s, 3H), 2.10 (s, 3H); 13C
NMR (100 MHz, CDCl3) δ 170.1, 158.4, 155.7, 142.4, 137.1,
117.0, 114.4, 110.5, 107.3, 99.6, 76.3, 53.0, 37.2, 15.3; IR
160.6, 143.4, 141.0, 131.8 (d, JCF = 0.3 Hz), 130.0 (d, JCF
=
7 Hz), 129.0 (d, JCF = 7 Hz), 115.8 (d, JCF = 17 Hz), 115.5 (d,
JCF = 17 Hz), 77.5, 77.3, 52.4, 49.0, 46.3, 41.6, 27.1; IR (neat):
2148, 1711, 1675, 1649, 1550, 1510, 1437 cm−1; HRMS (ESI)
for C25H23F2N4O8 [M + H]+ calcd 545.1484; found 545.1492.
Synthesis of methyl 2,6-dihydroxy-3-methyl-5-[1-(4-trifluoro-
methylphenyl]-2-nitroethyl)benzoate (12d) and methyl 3,7-
dioxo-4,6-[1-(4-trifluoromethylphenyl)-2-nitroethyl]-2-diazooct-
5-enoate (13d). To a 4 dram vial was added zinc triflate (2 mg,
0.005 mmol), followed by enone 2 (50 mg, 0.45 mmol) and
2 mL of dry DCM. The mixture was stirred at room temperature.
Enol diazoacetate 1 (180 mg, 0.70 mmol) was added all at once.
The yellow solution was allowed to react overnight. After 16 h,
2.0 equiv. of solid 4-trifluoromethyl-β-nitrostyrene (216 mg,
1.00 mmol) was added to the solution followed by triethylamine
(3 mg, 0.03 mmol, 5 mol%) when the 4-trifluoromethyl-β-nitros-
tyrene was fully dissolved. Reaction was performed as for the
synthesis of 12a and 13a. The resulting solution was concen-
trated under reduced pressure, and the residue was purified by
silica gel chromatography, eluting with 1 : 6 EtOAc–hexane, to
give 87 mg (0.26 mmol, 57%) of 12d as pale yellow oil then
48 mg (0.075 mmol, 17%) and 13d as a yellow syrup which is a
3 : 1 mixture of two diastereomers that could not be separated by
chromatography.
(neat): 3392, 3125, 2967, 2923, 1669, 1626, 1545, 1437 cm−1
;
HRMS (ESI) for C15H16NO7 [M + H]+ calcd 322.0927; found
322.0906.
Methyl 2,6-dihydroxy-3-methyl-5-[1-(4-trifluoromethyl-
phenyl)-2-nitroethyl]benzoate (12d). 1H NMR (400 MHz,
CDCl3) δ 10.02 (br, 1H), 9.87 (br, 1H), 7.57 (d, J = 8.0 Hz),
7.42 (d, J = 8.0 Hz), 7.02 (s, 1H), 5.19 (t, J = 8.0 Hz) 5.09 (dd,
J = 8.0 Hz, 12.0 Hz), 5.02 (dd, J = 8.0 Hz, 12.0 Hz), 4.07
(s, 3H), 2.11 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 170.1,
158.3, 155.9, 143.1, 136.7, 134.6, 129.6 (d, JCF = 30 Hz),
129.4, 128.2, 125.7(d, JCF = 3 Hz), 124.0 (q, JCF = 270 Hz),
99.8, 77.2, 53.1, 43.2, 15.3; IR (neat): 3435, 3110, 2965, 2924,
1674, 1621, 1553, 1439 cm−1; HRMS (ESI) for C18H17F3NO6
[M + H]+ calcd 400.1008; found. 400.1014.
Acknowledgements
The support of the National Institutes of Health (GM 46503) for
this research is gratefully acknowledged.
Notes and references
1 R. B. Durairaj, Resorcinol: Chemistry, Technology, and Applications,
Springer, New York, 2005.
2 H. Dressler, Resorcinol: Its Uses and Derivatives, Plenum Press,
New York, 1994.
3 S. Khaitb, O. Nerya, R. Musa, S. Tamir, T. Peter and J. Vaya, J. Med.
Chem., 2007, 50, 2676.
4 S. Shen and B. S. J. Blagg, Org. Lett., 2005, 7, 2157.
5 Y. Kang, Y. Mei, Y. Du and Z. Jin, Org. Lett., 2003, 5, 4481.
6 G. Liu, Z. Xin, H. Liang, C. Abad-Zapatero, P. J. Hajduk,
D. A. Janowick, B. G. Szczepankiewicz, Z. Pei, C. W. Hutchins,
Methyl 3,7-dioxo-4,6-[1-(4-trifluorophenyl)-2-nitroethyl]-2-
diazooct-5-enoate (13d). Major isomer: 1H NMR (400 MHz,
CDCl3) δ 7.59 (d, J = 8.0 Hz, 2H), 7.53 (d, J = 8.0 Hz, 2H),
7.42 (d, J = 8.0 Hz, 2H), 7.20 (d, J = 8.0 Hz, 2H), 6.89 (d, J =
This journal is © The Royal Society of Chemistry 2012
Org. Biomol. Chem., 2012, 10, 6388–6394 | 6393